HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2

por Peidis, Philippos, Papadakis, Andreas I., Rajesh, Kamindla, Koromilas, Antonis E.
Publicado 2010

Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications

por Krishnamoorthy, Jothilatha, Rajesh, Kamindla, Mirzajani, Farzaneh, Kesoglidou, Polixenia, Papadakis, Andreas I, Koromilas, Antonis E
Publicado 2014

eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies

por Rajesh, Kamindla, Papadakis, Andreas I., Kazimierczak, Urszula, Peidis, Philippos, Wang, Shuo, Ferbeyre, Gerardo, Kaufman, Randal J., Koromilas, Antonis E.
Publicado 2013

The eIF2α serine 51 phosphorylation-ATF4 arm promotes HIPPO signaling and cell death under oxidative stress

por Rajesh, Kamindla, Krishnamoorthy, Jothilatha, Gupta, Jyotsana, Kazimierczak, Urszula, Papadakis, Andreas I., Deng, Zhilin, Wang, Shuo, Kuninaka, Shinji, Koromilas, Antonis E.
Publicado 2016